This review aims to function as a comprehensive reference for clinical and laboratory findings for clinicians who are confronted with pediatric and adult patients with a possible diagnosis of a lcFAOD
Long-term considerations include planning for treatment duration, potential dose adjustments, management of weight plateaus, and strategies for maintaining weight loss if treatment is eventually discontinued
Treatments, results, and candidacy vary by individual
Therapy for BED Binge eating disorder treatment employs many of the same therapeutic approaches as other eating disorders
Drosophila Antimicrobial peptides and lysozymes regulate gut microbiota composition and abundance
BPC-157 promotes localized repair, angiogenesis, and gut healing, while TB-500 provides systemic anti-inflammatory and tissue-remodeling benefits